Central Nervous System
Experts in overcoming complexity, executing globally for your CNS study.
Clinical development of products treating diseases of the central nervous system (CNS) is uniquely complex. Challenges include successful and timely patient enrollment, reliance on subjective outcome measures, understanding factors that impact placebo response, and ensuring treatment adherence.
With a track record of superior signal detection, achieve faster, more reliable results by tapping into the depth of experience and services that include:
|
Alzheimer’s disease Multiple Sclerosis Parkinson’s disease Pain Epilepsy Stroke Migraine Sleep Disorders |
Schizophrenia Bipolar Disorders Depression Anxiety Addiction Disorders ADHD |
At Quintiles we can strategically develop and execute plans to reduce the impact of your challenges with our:
- Detailed approach to training investigators and executing trials.
- Worldwide medical and operational personnel.
- Data driven teams.
- Commercial team with neuroscience experience in the US.
Learn more about our specialized approach to clinical development in psychiatry and neurology.
Contact us to learn more about the many ways we can support the commercial viability of your CNS product.
